Insights into Gene Regulation under Temozolomide-Promoted Cellular Dormancy and Its Connection to Stemness in Human Glioblastoma by Carolin Kubelt, Dana Hellmold, Daniela Esser, Hajrullah Ahmeti, Michael Synowitz, Janka Held-Feindt

Get full text

Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche by Deniz Caylioglu, Rieke Johanna Meyer, Dana Hellmold, Carolin Kubelt, Michael Synowitz, Janka Held-Feindt

Get full text

Fabrication and Modelling of a Reservoir-Based Drug Delivery System for Customizable Release by Margarethe Hauck, Jan Dittmann, Berit Zeller-Plumhoff, Roshani Madurawala, Dana Hellmold, Carolin Kubelt, Michael Synowitz, Janka Held-Feindt, Rainer Adelung, Stephan Wulfinghoff, Fabian Schütt

Get full text

Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells by Dana Hellmold, Carolin Kubelt, Tina Daunke, Silje Beckinger, Ottmar Janssen, Margarethe Hauck, Fabian Schütt, Rainer Adelung, Ralph Lucius, Jochen Haag, Susanne Sebens, Michael Synowitz, Janka Held-Feindt

Get full text

Establishment of a Rodent Glioblastoma Partial Resection Model for Chemotherapy by Local Drug Carriers—Sharing Experience by Carolin Kubelt, Dana Hellmold, Eva Peschke, Margarethe Hauck, Olga Will, Fabian Schütt, Ralph Lucius, Rainer Adelung, Regina Scherließ, Jan-Bernd Hövener, Olav Jansen, Michael Synowitz, Janka Held-Feindt

Get full text